Philippe Moris

4.2k total citations
54 papers, 2.8k citations indexed

About

Philippe Moris is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Philippe Moris has authored 54 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 25 papers in Immunology and 18 papers in Infectious Diseases. Recurrent topics in Philippe Moris's work include Influenza Virus Research Studies (12 papers), Malaria Research and Control (12 papers) and Respiratory viral infections research (10 papers). Philippe Moris is often cited by papers focused on Influenza Virus Research Studies (12 papers), Malaria Research and Control (12 papers) and Respiratory viral infections research (10 papers). Philippe Moris collaborates with scholars based in Belgium, United States and United Kingdom. Philippe Moris's co-authors include Opokua Ofori‐Anyinam, Emmanuel Hanon, Geert Leroux‐Roels, Joe Cohen, Frédéric Clément, Erik Jongert, Francis Dessy, Marie‐Ange Demoitié, Isabel Leroux‐Roels and Sandro Giannini and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Philippe Moris

53 papers receiving 2.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Philippe Moris	1.4k	1.3k	918	653	546	54	2.8k
Patricia A. Darrah	2.5k 1.8×	1.2k 0.9×	1.5k 1.6×	720 1.1×	488 0.9×	37	4.0k
Ricardo E. Tascon	1.4k 1.0×	1.0k 0.8×	1.3k 1.4×	900 1.4×	317 0.6×	31	2.6k
Susan L. Baldwin	1.7k 1.2×	1.5k 1.1×	1.8k 2.0×	824 1.3×	174 0.3×	65	3.1k
Anja Seubert	1.5k 1.1×	888 0.7×	556 0.6×	673 1.0×	173 0.3×	31	2.5k
Nathalie Winter	1.6k 1.2×	1.3k 1.0×	1.6k 1.8×	699 1.1×	166 0.3×	72	3.4k
Thomas Ebensen	1.3k 0.9×	692 0.5×	495 0.5×	691 1.1×	268 0.5×	80	2.4k
Donata Medaglini	1.1k 0.8×	455 0.3×	1.1k 1.1×	879 1.3×	207 0.4×	97	2.9k
Malcolm S. Duthie	1.5k 1.1×	2.3k 1.8×	2.0k 2.2×	627 1.0×	1.2k 2.3×	147	4.7k
H. Snippe	1.1k 0.8×	1.6k 1.2×	775 0.8×	1.1k 1.7×	549 1.0×	156	3.6k
Chikara Aizawa	1.4k 1.0×	1.3k 1.0×	553 0.6×	379 0.6×	140 0.3×	55	2.6k

Countries citing papers authored by Philippe Moris

Since Specialization

Citations

This map shows the geographic impact of Philippe Moris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Moris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Moris more than expected).

Fields of papers citing papers by Philippe Moris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Moris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Moris. The network helps show where Philippe Moris may publish in the future.

Co-authorship network of co-authors of Philippe Moris

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Moris. A scholar is included among the top collaborators of Philippe Moris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Moris. Philippe Moris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leroux‐Roels, Isabel, Jacques Bruhwyler, Nicola Groth, et al.. (2024). Evaluation of Safety, Immunogenicity and Cross-Reactive Immunity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, in Older Adults. Vaccines. 12(12). 1391–1391. 2 indexed citations

Friberg, Heather, Amanda M. Kong, Leyi Lin, et al.. (2022). Characterization of B-cell and T-cell responses to a tetravalent dengue purified inactivated vaccine in healthy adults. npj Vaccines. 7(1). 132–132. 7 indexed citations

Cicconi, Paola, Claire Jones, Laura Silva-Reyes, et al.. (2019). First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector–Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults. Clinical Infectious Diseases. 70(10). 2073–2081. 43 indexed citations

Cicconi, Paola, Claerwen M. Jones, Laura Silva-Reyes, et al.. (2019). First-in-human randomized study to assess the safety and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine based on ChAd155 viral vector expressing RSV viral proteins F, N and M2-1 in healthy adults.. Clinical Infectious Diseases. 4 indexed citations

Wilkinson, Tom, Stuart Schembri, Christopher E. Brightling, et al.. (2019). Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trial. Vaccine. 37(41). 6102–6111. 41 indexed citations

Kumarasamy, Nagalingeswaran, Selvamuthu Poongulali, Anne Bollaerts, et al.. (2016). A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults. Medicine. 95(3). e2459–e2459. 35 indexed citations

Bourguignon, Patricia, Frédéric Clément, Marguerite Koutsoukos, et al.. (2014). Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naïve HIV-1-infected patients. Journal of Immunological Methods. 414. 1–10. 17 indexed citations

Couch, Robert B., José M. Bayas, Innocent N. Mbawuike, et al.. (2014). Superior antigen-specific CD4+T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older. BMC Infectious Diseases. 14(1). 425–425. 28 indexed citations

Damme, Pierre Van, Geert Leroux‐Roels, Philippe Simon, et al.. (2014). Effects of varying antigens and adjuvant systems on the immunogenicity and safety of investigational tetravalent human oncogenic papillomavirus vaccines: Results from two randomized trials. Vaccine. 32(29). 3694–3705. 19 indexed citations

10.

Leroux‐Roels, Geert, Isabel Leroux‐Roels, Frédéric Clément, et al.. (2014). Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines. Human Vaccines & Immunotherapeutics. 10(8). 2211–2219. 45 indexed citations

11.

Leroux‐Roels, Isabel, Jeanne‐Marie Devaster, Geert Leroux‐Roels, et al.. (2013). Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: Randomised, controlled trials. Vaccine. 33(4). 577–584. 52 indexed citations

12.

Gillard, Paul, Adrian Caplanusi, Markus Knuf, et al.. (2012). An assessment of prime‐boost vaccination schedules with AS03_A‐adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults. Influenza and Other Respiratory Viruses. 7(1). 55–65. 28 indexed citations

13.

Spertini, François, R Audran, Opokua Ofori‐Anyinam, et al.. (2012). The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: A randomized controlled phase I/II study. Tuberculosis. 93(2). 179–188. 42 indexed citations

14.

Ndungu, Francis M., Jedidah Mwacharo, Domtila Kimani, et al.. (2012). A Statistical Interaction between Circumsporozoite Protein-Specific T Cell and Antibody Responses and Risk of Clinical Malaria Episodes following Vaccination with RTS,S/AS01E. PLoS ONE. 7(12). e52870–e52870. 30 indexed citations

15.

Lumsden, Joanne M., Robert Schwenk, Lisa Rein, et al.. (2011). Protective Immunity Induced with the RTS,S/AS Vaccine Is Associated with IL-2 and TNF-α Producing Effector and Central Memory CD4+ T Cells. PLoS ONE. 6(7). e20775–e20775. 68 indexed citations

16.

Olotu, Ally, Philippe Moris, Jedidah Mwacharo, et al.. (2011). Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S/AS01E and Protection against P falciparum Clinical Malaria. PLoS ONE. 6(10). e25786–e25786. 72 indexed citations

17.

Kester, Kent E., James F. Cummings, Opokua Ofori‐Anyinam, et al.. (2009). Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection. The Journal of Infectious Diseases. 200(3). 337–346. 369 indexed citations

18.

Giannini, Sandro, Emmanuel Hanon, Philippe Moris, et al.. (2006). Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only. Vaccine. 24(33-34). 5937–5949. 391 indexed citations

19.

Vandepapelière, Pierre, Barbara Rehermann, Marguerite Koutsoukos, et al.. (2004). Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults. Vaccine. 23(20). 2591–2601. 38 indexed citations

20.

Alexandre, Isabelle, Nathalie Zammatteo, Philippe Moris, Françoise Brancart, & José Remacle. (1997). Comparison of three luminescent assays combined with a sandwich hybridization for the measurement of PCR-amplified human cytomegalovirus DNA. Journal of Virological Methods. 66(1). 113–122. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact